By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Isconova AB 

Kungsgatan 109

Uppsala    SE-751 83  Sweden
Phone: 46-18-161700 Fax: 46-18-161701


SEARCH JOBS


Industry
Biotechnology

Segment
Vaccines





Company News
Isconova Interim Report January – June 2013 8/27/2013 9:02:08 AM
Isconova Applies for Delisting 8/22/2013 9:47:18 AM
Novavax, Inc. (NVAX) Acquires Isconova; Extends Public Tender Offer Period for Remaining Isconova Shareholders 7/31/2013 9:40:40 AM
Novavax, Inc. (NVAX) and Isconova to Combine; Novavax' Swedish Prospectus Approved 7/8/2013 9:47:29 AM
Novavax, Inc. (NVAX) Offers to Buy All Outstanding Shares of Isconova for $29.6 Million 6/4/2013 9:31:57 AM
Isconova to Present at "Influenza Vaccines for the World Conference" 10/11/2012 10:59:19 AM
Isconova's Adjuvant Matrix-M™ in Clinical Trial With Malaria Vaccine 10/8/2012 10:54:37 AM
Isconova Carries Out a Fully Guaranteed Rights Issue of Approximately SEK 50 Million 8/27/2012 11:44:31 AM
Isconova's Adjuvant Matrix-M Approved by FDA for an IND Clinical Trial 8/15/2012 10:22:59 AM
Isconova Concludes Partnership With Virbac S.A. (FR:PVIRP) 7/25/2012 9:40:58 AM
123
//-->